Five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine, a heart medication known as TMZ, as announced by the International Tennis Integrity Agency on Thursday.
Swiatek failed an out-of-competition drug test in August, with the ITIA accepting her explanation that the result was unintentional. The positive test was attributed to the contamination of a nonprescription medication, melatonin, which Swiatek was taking for jet lag and sleeping issues.
